379 results
Page 9 of 19
8-K
y7nrb7msyx vs
2 Feb 11
Discovery Labs Provides Expanded Update Regarding its Program for Surfaxin® U.S. Marketing Authorization
12:00am
8-K
9x0g3 qxce
10 Jan 11
Discovery Labs Provides Update Regarding its Program for Surfaxin® U.S. Marketing Authorization
12:00am
DEFA14A
p7r6co0i z81ww3ffqoa
3 Dec 10
Additional proxy soliciting materials
12:00am
8-K
ktkmdd3mhduwwp 5w8
3 Dec 10
Discovery Labs Receives Nasdaq Delisting Notification
12:00am
CORRESP
p9xiv vsme1da1l
10 Nov 10
Correspondence with SEC
12:00am
8-K
uvnkjsk
9 Nov 10
Results of Operations and Financial Condition
12:00am
CORRESP
80766yous9du
8 Nov 10
Correspondence with SEC
12:00am
424B5
og92v6qe
13 Oct 10
Prospectus supplement for primary offering
12:00am
8-K
vhl6vafvn yb5
15 Sep 10
Departure of Directors or Certain Officers
12:00am
8-K
m51sbl1ycd0a
4 Aug 10
Discovery Labs Provides Business Update and Reports Second Quarter 2010 Financial Results
12:00am
424B5
pshii35i
18 Jun 10
Prospectus supplement for primary offering
12:00am
424B5
w4e9hz3p2s5eb4 ugr3
16 Jun 10
Prospectus supplement for primary offering
12:00am
424B3
9dll8w0
15 Jun 10
Prospectus supplement
12:00am
8-K
zzhl jopb
4 Jun 10
Discovery Labs Announces Listing Transfer to NASDAQ Capital Market
12:00am
8-K
1jl86t
21 May 10
Discovery Labs Achieves Key Milestone Towards Potential Surfaxin® Approval
12:00am